Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Moderna Inc (NQ: MRNA)
55.54   +3.36 (+6.44%)
Official Closing Price  /  Updated: 4:35 PM EDT, May 28, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 32,127,453
Open 53.50
Bid (Size) 55.60 (11)
Ask (Size) 55.70 (14)
Prev. Close 52.18
Today's Range 53.35 - 59.11
52wk Range 11.54 - 87.00
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+188.82%
+188.82%
1 Month
+15.59%
+15.59%
3 Month
+90.47%
+90.47%
6 Month
+172.66%
+172.66%
1 Year
+157.85%
+157.85%
Top News
More News
Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of Fabrice Chouraqui to the newly... Read More
from PR Newswire
Should You Own These Biotech Stocks?
from Stockmarket.com
More News
Read More
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
from PR Newswire
Moderna, Inc. Investors: Company Investigated by the Portnoy Law Firm
from GlobeNewswire News Releases
Moderna Expands Deal With CDMO To Source Raw Material For Coronavirus Vaccine
category Benzinga , Coronavirus , Market News , and 7 more.
from Benzinga
Moderna Expands Deal With CDMO To Source Raw Material For Coronavirus Vaccine
category Healthcare , Stocks / Equities
from Blogs - TalkMarkets
UPDATE 3-GSK aims for 1 bln doses of booster as COVID-19 vaccine race heats up
category companyNews
from Reuters: Company News
GlaxoSmithKline Plans to Produce 1 Billion Doses of Its Pandemic Vaccine Adjuvant in 2021
category MRNA , Market News , GSK
from Motley Fool
UPDATE 2-Moderna extends lipids deal to boost COVID-19 vaccine candidate output
category companyNews
from Reuters: Company News
UPDATE 1-Moderna extends lipids deal to boost COVID-19 vaccine output
category companyNews
from Reuters: Company News
CordenPharma extends deal with Moderna to supply lipids for COVID-19 vaccine
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.